MYR 0.08
(7.14%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -5.51 Million MYR | 29.6% |
2022 | -7.83 Million MYR | -262.5% |
2021 | 4.82 Million MYR | 140.76% |
2020 | -11.82 Million MYR | -430.06% |
2019 | -2.23 Million MYR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 Q2 | -1.16 Million MYR | -25.21% |
2023 Q1 | -932 Thousand MYR | 94.02% |
2023 Q4 | -1 Million MYR | 58.22% |
2023 Q3 | -2.41 Million MYR | -106.51% |
2022 Q2 | 1.31 Million MYR | 185.62% |
2022 Q1 | 459 Thousand MYR | 0.0% |
2022 FY | -8.12 Million MYR | -268.59% |
2022 Q4 | -15.59 Million MYR | -1967.66% |
2022 Q3 | 835 Thousand MYR | -36.31% |
2021 FY | 4.82 Million MYR | 140.76% |
2020 FY | -11.82 Million MYR | -430.06% |
2019 FY | -2.23 Million MYR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
QES Group Berhad | 18.46 Million MYR | 129.862% |
Optimax Holdings Berhad | 12.89 Million MYR | 142.782% |
Pharmaniaga Berhad | -80.16 Million MYR | 93.12% |
Apex Healthcare Berhad | 397.98 Million MYR | 101.386% |